Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Interventional, Registry Study for Chinese Gastric Cancer Patients With HER2 Status: Clinical and Pathological Characteristics, Treatment Patterns and Clinical Outcomes (EVIDENCE)

NCT01839500 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01839500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01839500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Interventional, Registry Study for Chinese Gastric Cancer Patients With HER2 Status: Clinical and Pathological Characteristics, Treatment Patterns and Clinical Outcomes (EVIDENCE)
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
April 25, 2013
Completion date
January 9, 2018
Enrollment
1,600 (estimated)
Sites
81

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer